Free Trial

Cassava Sciences (SAVA) Stock Forecast & Price Target

$12.33
+0.82 (+7.12%)
(As of 07/15/2024 ET)

Cassava Sciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$131.00
962.45% Upside
High Forecast$131.00
Average Forecast$131.00
Low Forecast$131.00
TypeCurrent Forecast
7/17/23 to 7/16/24
1 Month Ago
6/17/23 to 6/16/24
3 Months Ago
4/18/23 to 4/17/24
1 Year Ago
7/17/22 to 7/17/23
Consensus Rating
Hold
Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$131.00$131.00$124.00$38.81
Forecasted Upside962.45% Upside507.61% Upside450.87% Upside69.94% Upside
Get Cassava Sciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SAVA and its competitors with MarketBeat's FREE daily newsletter.

SAVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SAVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cassava Sciences Stock vs. The Competition

TypeCassava SciencesMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.71
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside973.77% Upside984.37% Upside9.15% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/1/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
V. Bernardino
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
1/25/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Mamtani
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$31.43 ➝ $20.00-4.89%
11/29/2022Univest Sec
Subscribe to MarketBeat All Access for the recommendation accuracy rating
James Jang
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$8.57 ➝ $7.86-68.02%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 02:15 AM ET.

SAVA Forecast - Frequently Asked Questions

What is Cassava Sciences' forecast for 2024?

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Cassava Sciences is $131.00, with a high forecast of $131.00 and a low forecast of $131.00.

Should I buy or sell Cassava Sciences stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cassava Sciences in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SAVA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SAVA, but not buy additional shares or sell existing shares.

Does Cassava Sciences's stock price have much upside?

According to analysts, Cassava Sciences's stock has a predicted upside of 507.61% based on their 12-month stock forecasts.

Has Cassava Sciences been downgraded by Wall Street analysts recently?

Over the previous 90 days, Cassava Sciences's stock had 1 downgrade by analysts.

What analysts cover Cassava Sciences?

Cassava Sciences has been rated by research analysts at HC Wainwright in the past 90 days.

Do Wall Street analysts like Cassava Sciences more than its competitors?

Analysts like Cassava Sciences less than other "medical" companies. The consensus rating for Cassava Sciences is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SAVA compares to other companies.


This page (NASDAQ:SAVA) was last updated on 7/16/2024 by MarketBeat.com Staff

From Our Partners